School of Public Health, Department of Community Health and Prevention, Drexel University, 1505 Race Street, Philadelphia, PA 19102, USA.
Int J Drug Policy. 2010 Jul;21(4):306-14. doi: 10.1016/j.drugpo.2010.01.007. Epub 2010 Feb 6.
Ketamine is a dissociative anaesthetic that became increasingly popular in the club and rave scene in the 1980s and 1990s. Reports surfaced in the late 1990s indicating that ketamine was being injected in several U.S. cities by young injection drug users (IDUs). Since all studies on ketamine injection were cross-sectional, a longitudinal study was undertaken in 2005 to determine: characteristics of young IDUs who continue to inject ketamine; frequency of ketamine injection over an extended time period; risks associated with ongoing ketamine injection; and environmental factors that impact patterns of ketamine use.
Young IDUs aged 16-29 with a history of injecting ketamine (n=101) were recruited from public locations in Los Angeles and followed during a 2-year longitudinal study. A semi-structured instrument captured quantitative and qualitative data on patterns of ketamine injection and other drug use. A statistical model sorted IDUs who completed three or more interviews (n=66) into three groups based upon patterns of ketamine injection at baseline and follow-up. Qualitative analysis focused on detailed case studies within each group.
IDUs recruited at baseline were typically in their early 20s, male, heterosexual, white, and homeless. Longitudinal injection trajectories included: "Moderates," who injected ketamine several times per year (n=5); "Occasionals," who injected ketamine approximately once per year (n=21); and "Abstainers," who did not inject any ketamine during follow-up (n=40). Findings suggest that ketamine is infrequently injected compared to other drugs such as heroin, cocaine, and methamphetamine. Most IDUs who begin injecting ketamine will stop or curb use due to: negative or ambivalent experiences associated with ketamine; an inability to find the drug due to declining supply; or maturing out of injecting drugs more generally.
Reducing ketamine injection among young IDUs may best be accomplished by targeting particular groups of IDUs identified in this study, such as homeless youth and homeless travellers.
氯胺酮是一种分离麻醉剂,在 20 世纪 80 年代和 90 年代在俱乐部和锐舞场景中越来越受欢迎。20 世纪 90 年代末有报道称,一些美国城市的年轻注射吸毒者(IDU)开始注射氯胺酮。由于所有关于氯胺酮注射的研究都是横断面研究,因此在 2005 年进行了一项纵向研究,以确定:继续注射氯胺酮的年轻 IDU 的特征;在较长时间内注射氯胺酮的频率;与持续注射氯胺酮相关的风险;以及影响氯胺酮使用模式的环境因素。
从洛杉矶的公共场所招募了年龄在 16-29 岁之间、有注射氯胺酮史的年轻 IDU(n=101),并在为期 2 年的纵向研究中对其进行了随访。一个半结构化的工具收集了关于氯胺酮注射和其他药物使用模式的定量和定性数据。一个统计模型根据基线和随访时氯胺酮注射模式将完成三次或更多次访谈的 IDU(n=66)分为三组。定性分析侧重于每个组内的详细案例研究。
基线时招募的 IDU 通常年龄在 20 岁出头,男性,异性恋,白人,无家可归。纵向注射轨迹包括:“中度”,每年注射氯胺酮几次(n=5);“偶尔”,每年大约注射一次氯胺酮(n=21);“禁欲者”,在随访期间没有注射任何氯胺酮(n=40)。研究结果表明,与海洛因、可卡因和甲基苯丙胺等其他药物相比,氯胺酮的注射频率较低。大多数开始注射氯胺酮的 IDU 会停止或减少使用,原因是:与氯胺酮相关的负面或矛盾体验;由于供应减少而无法找到药物;或者更普遍地不再注射毒品。
通过针对本研究中确定的特定 IDU 群体,例如无家可归的青年和无家可归的旅行者,可能最有效地减少年轻 IDU 中的氯胺酮注射。